Vitamin D3 at 50x AI Attenuates the Decline in Paw Grip Endurance, but Not Disease Outcomes, in the G93A Mouse Model of ALS, and Is Toxic in Females

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Gianforcaro, Alexandro ^a,b   Solomon, Jesse A ^a,b   Hamadeh, Mazen J ^a,b,c  

^a York University   (Canada)

^b YORK UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY CONSTITUTION; BODY WEIGHT; BRAIN WEIGHT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENDURANCE; FEMALE; FOOD INTAKE; LIFESPAN; LOCOMOTION; MALE; MOTOR PERFORMANCE; MOUSE; MUSCLE MASS; NONHUMAN; ONSET AGE; OUTCOME ASSESSMENT; PARALYSIS; PAW GRIP ENDURANCE; SCORING SYSTEM; SEX DIFFERENCE; SURVIVAL; TOXICITY TESTING; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; ANIMAL; DIET SUPPLEMENTATION; DISEASE MODEL; DRUG EFFECTS; EATING; HAND STRENGTH; HINDLIMB; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BODY WEIGHT; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EATING; FEMALE; HAND STRENGTH; HINDLIMB; MALE; MICE; MICE, TRANSGENIC; PHYSICAL ENDURANCE; PSYCHOMOTOR PERFORMANCE;

EID: 84873528883     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030243     Document Type: Article

References (56)

1. Vucic S, Kiernan MC, (2009) Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis. Curr Mol Med 9: 255-272.
2. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, et al. (2007) How common are the "common" neurologic disorders? Neurology 68: 326-337.
3. Turner BJ, Talbot K, (2008) Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog Neurobiol 85: 94-134.
4. Patel BP, Hamadeh MJ, (2009) Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis. Clin Nutr 28: 604-617.
5. Hamadeh MJ, Rodriguez MC, Kaczor JJ, Tarnopolsky MA, (2005) Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn-superoxide dismutase mutant G93A mouse. Muscle Nerve 31: 214-220.
6. Hamadeh MJ, Tarnopolsky MA, (2006) Transient caloric restriction in early adulthood hastens disease endpoint in male, but not female, Cu/Zn-SOD mutant G93A mice. Muscle Nerve 34: 709-719.
7. Patel BP, Safdar A, Raha S, Tarnopolsky MA, Hamadeh MJ, (2010) Caloric restriction shortens lifespan through an increase in lipid peroxidation, inflammation and apoptosis in the G93A mouse, an animal model of ALS. PLoS One 5: e9386.
8. Miller RG, Mitchell JD, Lyon M, Moore DH (2007) Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev: CD001447.
9. Hamden K, Carreau S, Jamoussi K, Miladi S, Lajmi S, et al. (2009) 1Alpha,25 dihydroxyvitamin D3: therapeutic and preventive effects against oxidative stress, hepatic, pancreatic and renal injury in alloxan-induced diabetes in rats. J Nutr Sci Vitaminol (Tokyo) 55: 215-222.
10. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, et al. (2006) Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 83: 754-759.
11. Taniura H, Ito M, Sanada N, Kuramoto N, Ohno Y, et al. (2006) Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons. J Neurosci Res 83: 1179-1189.
12. Naveilhan P, Neveu I, Wion D, Brachet P, (1996) 1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport 7: 2171-2175.
13. Veenstra TD, Windebank AJ, Kumar R, (1997) 1,25-dihydroxyvitamin D3 regulates the expression of N-myc, c-myc, protein kinase C, and transforming growth factor-beta2 in neuroblastoma cells. Biochem Biophys Res Commun 235: 15-18.
14. Wang Y, Chiang YH, Su TP, Hayashi T, Morales M, et al. (2000) Vitamin D(3) attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology 39: 873-880.
15. Sanchez B, Lopez-Martin E, Segura C, Labandeira-Garcia JL, Perez-Fernandez R, (2002) 1,25-Dihydroxyvitamin D(3) increases striatal GDNF mRNA and protein expression in adult rats. Brain Res Mol Brain Res 108: 143-146.
16. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ, (2005) Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29: 21-30.
17. Prufer K, Veenstra TD, Jirikowski GF, Kumar R, (1999) Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. J Chem Neuroanat 16: 135-145.
18. Bischoff HA, Borchers M, Gudat F, Duermueller U, Theiler R, et al. (2001) In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 33: 19-24.
19. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, et al. (2011) The 2011 Dietary Reference Intakes for Calcium and Vitamin D: what dietetics practitioners need to know. J Am Diet Assoc 111: 524-527.
20. Enomoto T, Furuya Y, Tomimori Y, Mori K, Miyazaki JI, et al. (2010) Establishment of a new murine model of hypercalcemia with anorexia by overexpression of soluble receptor activator of NF-kappaB ligand using an adenovirus vector. J Bone Miner Metab.
21. Spach KM, Hayes CE, (2005) Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 175: 4119-4126.
22. Silva ME, Silva MEC, Silva ME, Nicoli JR, Bambirra EA, et al. (1993) Vitamin D overload and experimental Trypanosoma cruzi infection: parasitological and histopathological aspects. Comp Biochem Physiol Comp Physiol 104: 175-181.
23. Cantorna MT, Humpal-Winter J, DeLuca HF, (1999) Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. J Nutr 129: 1966-1971.
24. Cantorna MT, Munsick C, Bemiss C, Mahon BD, (2000) 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 130: 2648-2652.
25. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, et al. (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264: 1772-1775.
26. Gurney ME, (1994) Transgenic-mouse model of amyotrophic lateral sclerosis. N Engl J Med 331: 1721-1722.
27. Gianforcaro A, Hamadeh MJ, (2012) Dietary Vitamin D(3) Supplementation at 10x the Adequate Intake Improves Functional Capacity in the G93A Transgenic Mouse Model of ALS, a Pilot Study. CNS Neurosci Ther 18: 547-557.
28. NRC (1995) Nutrient requirements of laboratory animals. Washington, DC: National Academy Press.
29. Sango K, McDonald MP, Crawley JN, Mack ML, Tifft CJ, et al. (1996) Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nature Genetics 14: 348-352.
30. Weydt P, Hong SY, Kliot M, Moller T, (2003) Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport 14: 1051-1054.
31. Solomon JA, Tarnopolsky MA, Hamadeh MJ, (2011) One universal common endpoint in mouse models of amyotrophic lateral sclerosis. PLoS One 6: e20582.
32. Burne TH, Johnston AN, McGrath JJ, Mackay-Sim A, (2006) Swimming behaviour and post-swimming activity in Vitamin D receptor knockout mice. Brain Res Bull 69: 74-78.
33. Burne TH, McGrath JJ, Eyles DW, Mackay-Sim A, (2005) Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res 157: 299-308.
34. Minasyan A, Keisala T, Zou J, Zhang Y, Toppila E, et al. (2009) Vestibular dysfunction in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 114: 161-166.
35. Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, et al. (2003) Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144: 5138-5144.
36. Solomon JA, Gianforcaro A, Hamadeh MJ, (2011) Vitamin D3 deficiency differentially affects functional and disease outcomes in the G93A mouse model of amyotrophic lateral sclerosis. PLoS ONE 6: e29354.
37. Bischoff HA, Stahelin HB, Dick W, Akos R, Knecht M, et al. (2003) Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18: 343-351.
38. Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, et al. (2009) Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int 20: 315-322.
39. Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, et al. (2007) A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 55: 234-239.
40. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, et al. (2000) Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 15: 1113-1118.
41. Cantorna MT, Hayes CE, DeLuca HF, (1996) 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 93: 7861-7864.
42. Nataf S, Garcion E, Darcy F, Chabannes D, Muller JY, et al. (1996) 1,25 Dihydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis. J Neuropathol Exp Neurol 55: 904-914.
43. Garcion E, Nataf S, Berod A, Darcy F, Brachet P, (1997) 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Res Mol Brain Res 45: 255-267.
44. Neveu I, Naveilhan P, Jehan F, Baudet C, Wion D, et al. (1994) 1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Res Mol Brain Res 24: 70-76.
45. Cornet A, Baudet C, Neveu I, Baron-Van Evercooren A, Brachet P, et al. (1998) 1,25-Dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro. J Neurosci Res 53: 742-746.
46. Saporito MS, Brown ER, Hartpence KC, Wilcox HM, Vaught JL, et al. (1994) Chronic 1,25-dihydroxyvitamin D3-mediated induction of nerve growth factor mRNA and protein in L929 fibroblasts and in adult rat brain. Brain Res 633: 189-196.
47. Wang JY, Wu JN, Cherng TL, Hoffer BJ, Chen HH, et al. (2001) Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res 904: 67-75.
48. Birge SJ, Haddad JG, (1975) 25-hydroxycholecalciferol stimulation of muscle metabolism. J Clin Invest 56: 1100-1107.
49. Zhang ZL, Ding XF, Tong J, Li BY, (2011) Partial rescue of the phenotype in 1alpha-hydroxylase gene knockout mice by vitamin d3 injection. Endocr Res 36: 101-108.
50. Rowling MJ, Gliniak C, Welsh J, Fleet JC, (2007) High dietary vitamin D prevents hypocalcemia and osteomalacia in CYP27B1 knockout mice. J Nutr 137: 2608-2615.
51. Nashold FE, Spach KM, Spanier JA, Hayes CE, (2009) Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression. J Immunol 183: 3672-3681.
52. Fleet JC, Gliniak C, Zhang Z, Xue Y, Smith KB, et al. (2008) Serum metabolite profiles and target tissue gene expression define the effect of cholecalciferol intake on calcium metabolism in rats and mice. J Nutr 138: 1114-1120.
53. Vieth R, Milojevic S, Peltekova V, (2000) Improved cholecalciferol nutrition in rats is noncalcemic, suppresses parathyroid hormone and increases responsiveness to 1, 25-dihydroxycholecalciferol. J Nutr 130: 578-584.
54. Hughes MR, Baylink DJ, Gonnerman WA, Toverud SU, Ramp WK, et al. (1977) Influence of dietary vitamin D3 on the circulating concentration of its active metabolites in the chick and rat. Endocrinology 100: 799-806.
55. Reeves PG, Nielsen FH, Fahey GC Jr, (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939-1951.
56. Anon (1977) Report of the American Institute of Nutrition ad hoc Committee on Standards for Nutritional Studies. J Nutr 107: 1340-1348.